...UCB buying Engage for $125M UCB S.A. (Euronext:UCB) acquired Engage Therapeutics Inc. Friday, gaining Staccato alprazolam, a...

...will join Engage's board in conjunction with the financing. Mayes said Phase IIb testing of Staccato alprazolam...
...Avraham Pharmaceuticals Ltd. (Yavneh, Israel). Engage Therapeutics Inc. , Summit, N.J. Integra Holdings, Jerusalem, Israel Jennie Walters Staccato alprazolam Alexza...

...will join Engage's board in conjunction with the financing. Mayes said Phase IIb testing of Staccato alprazolam...
...of Jerusalem . The firm's portfolio includes Alzheimer's disease company Avraham Pharmaceuticals Ltd. (Yavneh, Israel). Jennie Walters Staccato alprazolam Alexza...

...U.S. Phase IIa trial showed that single doses of 0.5, 1 and 2 mg inhaled AZ-002...
...mg AZ-002 reduced mean SPR from baseline to 2 minutes by 42%; and 2 mg AZ-002...
...trial is enrolling 6 patients. Alexza Pharmaceuticals Inc. (NASDAQ:ALXA), Mountain View, Calif. Product: Staccato alprazolam ( AZ-002...

...in the EU and U.S. to treat agitation associated with schizophrenia. The company’s pipeline includes AZ-002...
...seizures, and AZ-007, which is in preclinical development to treat middle of the night waking. AZ-002...

...Staccato in about 6 patients. Alexza Pharmaceuticals Inc. (NASDAQ:ALXA), Mountain View, Calif. Product: Staccato alprazolam ( AZ-002...

...Alexza to re-acquire Staccato loxapine and its low-dose formulation AZ-104 , as well as Staccato alprazolam (AZ-002...

...Staccato loxapine ( AZ-004 ) and its low-dose formulation AZ-104 , as well as Staccato alprazolam (AZ-002...
...schizophrenia or bipolar disorder. AZ-104 is in Phase IIb testing to treat migraine. Last year, AZ-002...

...loxapine ( AZ-004 ) and its low-dose formulation AZ-104 , as well as Staccato alprazolam ( AZ-002...
...schizophrenia or bipolar disorder. AZ-104 is in Phase IIb testing to treat migraine. Last year, AZ-002...

...Staccato loxapine ( AZ-004 ) and its low-dose formulation AZ-104 , as well as Staccato alprazolam (AZ-002...
...schizophrenia or bipolar disorder. AZ-104 is in Phase IIb testing to treat migraine. Last year, AZ-002...